BofA/Merrill Made the Right Call, Amsurg 4.1% Higher (AMSG)

A week ago, BofA/Merrill upgraded Amsurg from Underperform to Buy. Amsurg shares are selling at $81.67, 4.1% above the $78.43 price point of one week ago.Potential upside of 12.3%...